Clinical Trial Update: Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1B [Phase 4]

View source ↗

Summary

Phase 4 proof-of-concept study evaluating OBV/PTV/r and DSV in adults with hepatitis C genotype 2k/1b, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• DSV
• OBV/PTV/r

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: HCV Coinfection | Phase 4 | Status: COMPLETED